MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling
Authors
Keywords
-
Journal
Life Science Alliance
Volume 3, Issue 6, Pages e201900545
Publisher
Life Science Alliance, LLC
Online
2020-05-08
DOI
10.26508/lsa.201900545
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Loss of TP63 promotes the metastasis of head and neck squamous cell carcinoma by activating MAPK and STAT3 signaling
- (2019) Senthilnath Lakshmanachetty et al. MOLECULAR CANCER RESEARCH
- Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer
- (2019) Matthew L. Hedberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
- (2019) Ezra E. W. Cohen et al. Journal for ImmunoTherapy of Cancer
- Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma
- (2018) Joshua R. Veatch et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutation burden in conjunction with MAPK-pathway mutation status as a prognostic biomarker of overall melanoma survival.
- (2018) John Cadley et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
- (2018) Diana Miao et al. NATURE GENETICS
- Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy
- (2018) Y -P Chen et al. ANNALS OF ONCOLOGY
- Quality of Life for Patients with Favorable Risk HPV-Associated Oropharyngeal Cancer After De-Intensified Chemoradiotherapy
- (2018) Kevin A. Pearlstein et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
- (2018) Hisham Mehanna et al. LANCET
- Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
- (2018) Maura L Gillison et al. LANCET
- Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma
- (2018) Douglas J. Hartman et al. ORAL ONCOLOGY
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
- (2017) Emma J. de Ruiter et al. OncoImmunology
- Toward a Shared Vision for Cancer Genomic Data
- (2016) Robert L. Grossman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erratum: Corrigendum: Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development
- (2016) Yu-Fan Liu et al. Scientific Reports
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma
- (2015) Eliezer M. Van Allen et al. JAMA Oncology
- ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models
- (2014) L. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Erk1/2 activation and modulation of STAT3 signaling in oral cancer
- (2014) IOANNIS GKOUVERIS et al. ONCOLOGY REPORTS
- T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
- (2014) I. Melero et al. Cancer Discovery
- Epidemiologic Trends in Head and Neck Cancer and Aids in Diagnosis
- (2014) Nadarajah Vigneswaran et al. Oral and Maxillofacial Surgery Clinics of North America
- TCPA: a resource for cancer functional proteomics data
- (2013) Jun Li et al. NATURE METHODS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
- (2013) V. W. Y. Lui et al. Cancer Discovery
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma
- (2011) Mikiko Takikita et al. Journal of Translational Medicine
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
- (2011) N. Stransky et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started